Oct-4 inhibitors are compounds that specifically target and inhibit the activity of the Octamer-binding transcription factor 4 (Oct-4), a member of the POU transcription factor family. Oct-4 plays a crucial role in maintaining the pluripotency and self-renewal capabilities of embryonic stem cells and is involved in regulating gene expression patterns associated with stem cell differentiation. Structurally, Oct-4 contains a POU-specific domain and a homeodomain, both of which are essential for DNA binding and transcriptional regulation. Inhibitors of Oct-4 typically interact with these domains to block the transcription factor's ability to bind to DNA, thus preventing the activation of specific genes that are essential for maintaining an undifferentiated state. This leads to alterations in gene expression patterns, driving differentiation or other cellular changes depending on the context of Oct-4 expression.
The inhibition of Oct-4 affects several molecular pathways that are integral to cellular development and differentiation processes. The mechanisms by which Oct-4 inhibitors operate often involve disrupting the interactions between Oct-4 and its co-factors, which may be required for its proper function. Some inhibitors may function by binding directly to the DNA-binding region of Oct-4, while others might affect upstream regulators of the transcription factor, altering its expression or stability. The structure-activity relationships (SAR) of these inhibitors are important for understanding how subtle modifications to the chemical structure of a compound can enhance or reduce its ability to inhibit Oct-4 effectively. Furthermore, such inhibitors provide a powerful tool for studying the biological functions of Oct-4, offering insights into the transcriptional networks governing cellular fate and the regulation of genes involved in developmental processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This cytidine analog could cause demethylation of the Oct-4 promoter region, leading to a decrease in Oct-4 transcription in stem cells. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
By specifically targeting G9a histone methyltransferase, this compound may reduce histone methylation at the Oct-4 gene locus, resulting in decreased Oct-4 mRNA synthesis. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
It may promote the differentiation of pluripotent cells, during which the Oct-4 gene is transcriptionally repressed as the cells lose pluripotency. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
It may block TGF-β receptor kinase activity, resulting in the reduced transcriptional activity of downstream targets, including genes like Oct-4. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
By inhibiting histone deacetylases, this compound could cause an increase in acetylated histones at the Oct-4 locus, leading to repression of Oct-4 gene transcription. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
The inhibition of the PI3K pathway by this compound may result in decreased activity of downstream transcription factors that drive Oct-4 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
It may inhibit mTOR signaling, which is necessary for the translation of many proteins including those that maintain Oct-4 transcription in stem cells. | ||||||
Ciglitazone | 74772-77-3 | sc-200902 sc-200902A | 5 mg 25 mg | $104.00 $428.00 | 10 | |
As a PPARγ agonist, it could trigger the differentiation of precursor cells into adipocytes, thereby decreasing Oct-4 expression as part of the differentiation cascade. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
It may lead to the hyperacetylation of histones around the Oct-4 gene, which could suppress its transcriptional initiation and reduce expression. | ||||||